Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

418.81
BATS BZX Real-Time Price
As of 3:48pm ET
 -2.64 / -0.63%
Today’s Change
329.09
Today|||52-Week Range
592.59
-22.85%
Year-to-Date
Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data
9:32am / Zacks.com - Paid Partner Content
3 Growth Stocks You Can Buy Cheap Right Now
Sep 26 / MotleyFool.com - Paid Partner Content
3 Top Dividend Stocks Selling for a Discount This Fall
8:05am / MotleyFool.com - Paid Partner Content
5 Stocks with Impressive Sales Growth to Bet On
Sep 26 / Zacks.com - Paid Partner Content
3 Critical FDA Decisions You Can't Afford to Miss
Sep 27 / MotleyFool.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Regeneron Pharmaceuticals, Nordstrom, Intel, Nu Skin E...
Sep 27 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content
Regeneron, Sanofi Skin Disease Drug Under Priority Review
Sep 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close421.45
Today’s open421.62
Day’s range418.35 - 424.10
Volume28,848
Average volume (3 months)814,322
Market cap$44.4B
Dividend yield--
Data as of 3:48pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-8.87%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+45.55%
P/E ratio65.4
Price/Sales15.24
Price/Book12.07

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.24-0.12%
ALXNAlexion Pharmaceutic...-2.21-1.75%
ABTAbbott Laboratories-0.02-0.04%
BAXBaxter International...+0.55+1.16%
Data as of 3:48pm ET, 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$2.72
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Search for Jobs